ArticleCancer research and treatment2026

Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea.

Jun Ho Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.